Results 1,741-1,760 of 11,979 for speaker:Billy Kelleher

Leaders' Questions (8 Nov 2017)

Billy Kelleher: Cardboard cutouts.

Leaders' Questions (8 Nov 2017)

Billy Kelleher: The Taoiseach needs to protect the service as well.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Billy Kelleher: I welcome the witnesses. I wish to make a few brief points on two issues that are very much to the fore at present. First, there is the new drug called Respreeza, which was developed by CSL Behring, and the reimbursement of same. There has been an extension to the compassionate programme. I hope that I have misread the situation because it is hard to believe that the HSE will not...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Billy Kelleher: Is it something I said? Is it a fire alarm?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (8 Nov 2017)

Billy Kelleher: I will continue along the same path. I was referring to the national rare diseases plan for Ireland, launched by the Minister in July 2014. The witnesses are aware of it. I tabled a parliamentary question recently which highlighted that quite a number of areas have not been fully implemented. These include recommendations Nos. 30 to 39, inclusive. Quite a number are in their infancy....

Written Answers — Department of Health: Services for People with Disabilities (8 Nov 2017)

Billy Kelleher: 150. To ask the Minister for Health if consideration has or will be given to providing an allowance to polio survivors for physiotherapy; and if he will make a statement on the matter. [47185/17]

Written Answers — Department of Health: General Practitioner Contracts (7 Nov 2017)

Billy Kelleher: 633. To ask the Minister for Health the number of occasions his Department or HSE officials have met the Irish Medical Organisation as part of the talks on a new general practitioners' contract to date in 2017. [45703/17]

Written Answers — Department of Health: General Practitioner Contracts (7 Nov 2017)

Billy Kelleher: 634. To ask the Minister for Health the number of occasions his Department or HSE officials have met the National Association of General Practitioners as part of the talks on a new general practitioners' contract to date in 2017 [45704/17]

Written Answers — Department of Health: Consultancy Contracts (7 Nov 2017)

Billy Kelleher: 635. To ask the Minister for Health the consultancy contracts his Department and the HSE have entered into since 1 January 2016; and the details of reports arising from such consultancy contracts that have been furnished to date to his Department and the HSE. [45705/17]

Written Answers — Department of Health: Rare Diseases Strategy Implementation (7 Nov 2017)

Billy Kelleher: 673. To ask the Minister for Health the action taken to implement recommendations 30 to 39 of the national rare disease plan on access to medicines and technologies, in tabular form [45915/17]

Written Answers — Department of Health: Drugs Payment Scheme Coverage (7 Nov 2017)

Billy Kelleher: 675. To ask the Minister for Health the orphan drugs considered for reimbursement by the National Centre for Pharmacoeconomics in each of the years from 2011 to 2016 and to date in 2017, by the year of final recommendation, in tabular form; and if each drug was recommended for reimbursement [45921/17]

Written Answers — Department of Health: Rare Diseases (7 Nov 2017)

Billy Kelleher: 677. To ask the Minister for Health if he will report on the work of the technical review committee for orphan drugs; the date of the committee's establishment; the membership of same; the chairperson of the committee; the date of their appointment; the number of meetings that have taken place; the recommendations that have been made by the committee; the action taken to implement...

Written Answers — Department of Health: Health Care Infrastructure Provision (7 Nov 2017)

Billy Kelleher: 682. To ask the Minister for Health the number of purchase orders processed by purchase officers in County Mayo since January 2017 in logistics and inventory management in respect of health business services; the number of persons that worked on theses purchase orders; the number at grade 4 and over; the combined salary of these persons; and if he will make a statement on the matter. [45951/17]

Written Answers — Department of Health: Health Services Provision (7 Nov 2017)

Billy Kelleher: 683. To ask the Minister for Health if a case review will be carried out for a person (details supplied); and if he will make a statement on the matter. [45956/17]

Written Answers — Department of Health: Medicinal Products Reimbursement (7 Nov 2017)

Billy Kelleher: 684. To ask the Minister for Health the steps he will take regarding the unprecedented High Court appeal brought by a company (details supplied) against the HSE decision not to reimburse for translarna for the treatment of Duchenne muscular dystrophy for two children; and if he will make a statement on the matter. [45957/17]

Written Answers — Department of Health: Medicinal Products Reimbursement (7 Nov 2017)

Billy Kelleher: 685. To ask the Minister for Health if his Department or the HSE will work towards an interim arrangement to treat children with translarna; and if he will make a statement on the matter. [45958/17]

Written Answers — Department of Health: Medicinal Products Licensing (7 Nov 2017)

Billy Kelleher: 722. To ask the Minister for Health if his attention has been drawn to concerns regarding the way the European Medicines Agency 2014 recommendation that sodium valproate should not be prescribed for girls and women of childbearing age is being implemented [46307/17]

Written Answers — Department of Health: Medicinal Products Licensing (7 Nov 2017)

Billy Kelleher: 723. To ask the Minister for Health when sodium valproate was first prescribed here; and if there are estimates of the number of children that have been adversely impacted by it [46308/17]

Written Answers — Department of Health: Medicinal Products Licensing (7 Nov 2017)

Billy Kelleher: 725. To ask the Minister for Health if his attention has been drawn to the fact that an organisation (details supplied) has conducted a number of surveys of women taking valproate and found that while doctor patient communication is improving since 2014, only 56% of women surveyed in December 2016 indicated that they have had discussions on this issue with their healthcare professionals and...

Written Answers — Department of Health: Medicinal Products Licensing (7 Nov 2017)

Billy Kelleher: 726. To ask the Minister for Health his views on whether the use of valproate information resources should be mandatory and informed consent should be obtained when using the drug in women and girls; his further views on whether a valproate register should be established and properly resourced public awareness campaigns need to happen; and his views on whether warnings should be displayed on...